RESEARCH NOTICE & LEGAL DISCLAIMER
FOR RESEARCH PURPOSES ONLY. All information provided within the Biolabs Peptides Research Centre is intended strictly for scientific, laboratory, and educational purposes.
-
Not Medical Advice: The protocols and data presented herein do not constitute medical advice, nursing advice, or a professional healthcare diagnosis.
-
Non-Therapeutic: These peptides are not intended to diagnose, treat, cure, or prevent any medical condition or disease.
-
Researcher Responsibility: Any research conducted should be performed by qualified professionals in a controlled laboratory environment. By accessing this data, you acknowledge that you are responsible for following your local laws and institutional safety guidelines.
LL-37 (CAP-18) 5 mg Vial: Dosage Protocol (3 mL Dilution)
LL-37 is a human-derived antimicrobial peptide researched for its broad-spectrum antibacterial activity, immune-modulating properties, and its role in accelerating wound healing.
1. Reconstitution (Mixing)
-
Diluent: Add 3.0 mL of Bacteriostatic Water to your 5 mg vial.
-
Concentration: This creates a 1.67 mg/mL solution.
-
Measurement: On a standard U-100 (1 mL) insulin syringe:
-
1 Unit ≈ 16.7 mcg
-
3 Units ≈ 50 mcg
-
6 Units ≈ 100 mcg
-
Reconstitution Steps:
-
Draw 3.0 mL of bacteriostatic water into a sterile syringe.
-
Inject the water slowly down the inside wall of the vial to avoid foaming.
-
Gently swirl or roll the vial between your hands until the powder is fully dissolved. Do not shake.
-
Label the vial and store in the refrigerator.
2. The Titration Schedule
(Doses are administered via subcutaneous injection once daily)
Week Daily Dose (mcg) Syringe Volume (Units)
Week 1 50 mcg 3 Units
Week 2 100 mcg 6 Units
Week 3 150 mcg 9 Units
Week 4 200 mcg 12 Units
Week 5 250 mcg 15 Units
Week 6 300 mcg 18 Units
Week 7 350 mcg 21 Units
Week 8 400 mcg 24 Units
Note: Some research protocols utilize a "5-days-on, 2-days-off" schedule to maintain sensitivity.
3. Administration & Storage
-
Method: Subcutaneous injection into the abdomen, thigh, or upper arm. Rotate sites daily.
-
Precision Tip: Because early doses are very small (under 10 units), using 30-unit or 50-unit insulin syringes will provide much better accuracy and readability.
-
Storage: * Unopened Vials: Store in the freezer at -20°C.
-
Reconstituted Vials: Store in the refrigerator (2°C – 8°C) and protect from light. Use within 4 weeks. Avoid repeated freeze-thaw cycles.
-
4. Supplies Needed (8-Week Cycle)
To complete a standard 8-week protocol, you will typically require:
-
Peptide: 3 vials of LL-37 (5 mg each).
-
Syringes: ~60 insulin syringes (one per day).
-
Water: 1 bottle (10 mL) of Bacteriostatic Water.
-
Swabs: 2 boxes of alcohol swabs (one for the vial, one for the skin).
SAHPRA COMPLIANCE & LEGAL DISCLAIMER
ATTENTION: This product is NOT REGISTERED with the South African Health Products Regulatory Authority (SAHPRA).
-
This medicine has not been evaluated by SAHPRA for its quality, safety, or intended use.
-
LL-37 is currently an investigational compound and is not approved for the treatment of infections, wound healing, or any other medical condition in South Africa.
-
In terms of the Medicines and Related Substances Act (Act 101 of 1965), the use of unregistered medicines is generally restricted to authorized clinical trials or specific Section 21 authorizations.
-
WARNING: Compounded or unregistered peptides have been flagged by SAHPRA as potentially "undesirable" due to risks of contamination, incorrect dosing, and lack of sterile oversight. Use of this substance is at the user’s own risk. Consult a registered medical practitioner before use.
Medical Notice: This document is for informational purposes only and does not replace professional medical advice. If you experience any adverse reactions or signs of an allergic response, discontinue use and seek immediate medical attention.